Perinatal and prenatal toxicity studies (segment I and III) MCQs With Answer

This quiz set focuses on perinatal and prenatal toxicity studies (segments I and III) relevant to M.Pharm students studying Pharmacological & Toxicological Screening Methods-II. It covers study objectives, design elements, endpoints, species selection, timing of dosing, data interpretation, and regulatory guidelines. Questions emphasize practical distinctions between maternal and developmental toxicity, litter-based statistical considerations, fetal examinations (external, visceral, skeletal), and procedures such as cross-fostering and cesarean examination. The aim is to reinforce conceptual understanding and prepare students for designing, analyzing, and critiquing reproductive and developmental toxicity studies used in drug safety assessment.

Q1. Which of the following best describes the primary objective of a segment I reproductive toxicity study?

• To evaluate effects on embryo-fetal organogenesis during gestation
• To assess fertility and early embryonic development including implantation
• To assess offspring behavior and sexual maturation after birth
• To determine chronic toxicity in adult animals over 90 days

Correct Answer: To assess fertility and early embryonic development including implantation

Q2. In developmental toxicity testing, why is the litter considered the appropriate statistical unit for many endpoints?

• Because individual pup outcomes are always independent of littermates
• To avoid overestimating significance due to correlated outcomes within the same litter
• Because litter effects are negligible and therefore easier to analyze
• To simplify data collection by averaging maternal parameters only

Correct Answer: To avoid overestimating significance due to correlated outcomes within the same litter

Q3. Which OECD guideline specifically addresses prenatal developmental toxicity (embryo‑fetal) studies?

• OECD TG 408 — 90‑day subchronic toxicity
• OECD TG 414 — Prenatal Developmental Toxicity Study
• OECD TG 421 — Reproduction/Developmental Screening Test
• OECD TG 436 — Carcinogenicity studies

Correct Answer: OECD TG 414 — Prenatal Developmental Toxicity Study

Q4. During which gestational period are rodents typically dosed for embryo‑fetal developmental (organogenesis) studies?

• Pre‑mating only
• Organogenesis: around gestation day (GD) 6–15 in rats
• Entire gestation and lactation until weaning
• Postnatal days 1–21 only

Correct Answer: Organogenesis: around gestation day (GD) 6–15 in rats

Q5. Which outcome is most indicative of direct teratogenic effect rather than secondary effect from maternal toxicity?

• Embryolethality accompanied by severe maternal weight loss
• Isolated dose‑dependent structural malformations without maternal toxicity
• Reduced litter size associated with maternal food refusal
• Delayed fetal growth in presence of maternal severe systemic toxicity

Correct Answer: Isolated dose‑dependent structural malformations without maternal toxicity

Q6. In a perinatal (segment III) study assessing postnatal development, which period is most critical for evaluating neurobehavioral and functional maturation?

• Pre‑implantation only
• Organogenesis window (GD6–15)
• Late gestation through lactation and weaning (perinatal period)
• Adulthood after sexual maturity only

Correct Answer: Late gestation through lactation and weaning (perinatal period)

Q7. Which procedural step is commonly used to evaluate skeletal malformations in prenatal studies?

• Behavioral testing of adult offspring
• Staining of fetal skeleton with alizarin red or double staining
• Serum biochemical analysis of dams
• Measurement of maternal blood pressure

Correct Answer: Staining of fetal skeleton with alizarin red or double staining

Q8. What is the main rationale for performing cesarean section (C‑section) fetal examinations in prenatal developmental toxicity studies?

• To allow pups to nurse immediately after birth
• To obtain accurate intrauterine fetal data at a defined gestational day
• To measure maternal behavior under anesthesia
• To reduce the cost of postnatal follow‑up

Correct Answer: To obtain accurate intrauterine fetal data at a defined gestational day

Q9. Cross‑fostering (swapping pups between dams) in perinatal studies is primarily used to:

• Increase litter sizes for better statistical power
• Distinguish between direct offspring effects and altered maternal care or lactation
• Induce stress in pups to test resilience
• Ensure equal genetic background across groups

Correct Answer: Distinguish between direct offspring effects and altered maternal care or lactation

Q10. When interpreting developmental toxicity data, which NOAEL should be reported for regulatory decision making?

• The highest dose associated with any maternal effect, regardless of offspring data
• Separate NOAELs for maternal toxicity and for developmental (offspring) toxicity
• The lowest observed adverse effect level (LOAEL) only
• The NOAEL for adult chronic toxicity studies only

Correct Answer: Separate NOAELs for maternal toxicity and for developmental (offspring) toxicity

Q11. Which observation in a developmental study would most strongly suggest teratogenicity rather than growth retardation?

• Uniform reduction in fetal body weight across litters
• Transient delay in ossification that resolves postnatally
• Specific malformations such as limb or craniofacial defects
• Reduced pup viability due to poor lactation

Correct Answer: Specific malformations such as limb or craniofacial defects

Q12. For segment I fertility assessment in male rodents, pre‑mating dosing is important because it:

• Ensures drug accumulation in fetal tissues after conception
• Covers the spermatogenic cycle to detect effects on sperm development
• Prevents implantation by altering the uterine lining
• Is primarily for testing teratogenicity in males

Correct Answer: Covers the spermatogenic cycle to detect effects on sperm development

Q13. Which endpoint is typically evaluated in perinatal studies to assess functional development of offspring?

• Adult organ histopathology only
• Developmental landmarks, reflexes, and neurobehavioral tests
• Maternal estrous cyclicity after weaning
• Serum cholesterol levels in dams

Correct Answer: Developmental landmarks, reflexes, and neurobehavioral tests

Q14. In prenatal developmental studies, what is the importance of distinguishing between variations and malformations in fetal examination?

• There is no difference; both are treated equally
• Variations are minor, often transient changes; malformations are permanent structural defects of toxicological concern
• Variations indicate maternal toxicity while malformations indicate genetic drift
• Malformations are less important because they resolve after birth

Correct Answer: Variations are minor, often transient changes; malformations are permanent structural defects of toxicological concern

Q15. Which species is commonly preferred for regulatory prenatal developmental toxicity studies and why?

• Guinea pig because of short gestation and low cost
• Rat and rabbit: rat for mammalian consistency and rabbit for sensitivity to some teratogens
• Dog because it is phylogenetically closest to humans
• Non‑human primate because it is always required for regulatory approval

Correct Answer: Rat and rabbit: rat for mammalian consistency and rabbit for sensitivity to some teratogens

Q16. Which statistical approach is most appropriate when analyzing pup‑level continuous data that are potentially correlated within litters?

• Simple t‑test treating each pup as independent without adjustment
• Mixed‑effects model or analysis using litter as the unit to account for intra‑litter correlation
• Chi‑square test for continuous data
• Ignoring litter effects and pooling all pups across groups

Correct Answer: Mixed‑effects model or analysis using litter as the unit to account for intra‑litter correlation

Q17. In a perinatal toxicity study, a finding of reduced pup survival but normal maternal clinical signs could indicate:

• Maternal toxicity causing fetal loss
• Direct neonatal toxicity affecting lactation or pup viability
• An artifact due to laboratory handling unrelated to treatment
• Improved maternal care leading to cannibalism

Correct Answer: Direct neonatal toxicity affecting lactation or pup viability

Q18. Which of the following is an advantage of including a cross‑fostering component in a perinatal study?

• Removing variability by keeping pups with their biological mothers only
• Separating direct chemical effects on pups from effects mediated by maternal care or milk
• Reducing the number of animals required by sharing litters across groups
• Ensuring all pups receive identical genetic background

Correct Answer: Separating direct chemical effects on pups from effects mediated by maternal care or milk

Q19. When designing dose levels for a prenatal developmental study, which principle is most appropriate?

• Select doses based solely on maximum tolerated dose in adult chronic studies
• Include a high dose producing some maternal toxicity but not overwhelming lethality, plus lower doses to define NOAELs
• Use only a single dose to simplify interpretation
• Choose doses that cause 100% fetal malformations for sensitivity

Correct Answer: Include a high dose producing some maternal toxicity but not overwhelming lethality, plus lower doses to define NOAELs

Q20. Which procedural element ensures standardized detection of internal (visceral) fetal malformations?

• Visual inspection of live pups after birth only
• Systematic sectioning and dissection (e.g., Wilson technique) and fixation of fetuses for visceral examination
• Measuring maternal food consumption daily
• Relying exclusively on skeletal staining without soft tissue examination

Correct Answer: Systematic sectioning and dissection (e.g., Wilson technique) and fixation of fetuses for visceral examination

Download